Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Short-term topiramate in obese women with impaired fasting glucose
NL-OMON31914Phase 4Not yet recruiting
- Sponsor
- Lygature
- Start
- Mar 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of topiramate in obesity and impaired fasting glucose (IFG) (2 arms), sponsored by Lygature. Primary endpoints: Anthropometric measures, Glucose metabolism and 6 more. Planned start Mar 2008; status: not yet recruiting.
02
Drugs
topiramate
03
Conditions
obesityimpaired fasting glucose (IFG)
Beyond the preview
Go deeper on NL-OMON31914.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON31914.